|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/02 | |
| A61K 39/00 | |||
| A61K 39/39 | |||
| A61K 47/50 | |||
| A61K 47/64 |
| (11) | Number of the document | 2519265 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10818096.9 |
| Date of filing the European patent application | 2010-12-30 | |
| (97) | Date of publication of the European application | 2012-11-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2010/003484 |
| Date | 2010-12-30 |
| (87) | Number | WO 2011/080595 |
| Date | 2011-07-07 |
| (30) | Number | Date | Country code |
| 291262 P | 2009-12-30 | US |
| (72) |
COSTANTINO, Paolo, IT
SERINO, Laura, IT
ROMANO, Maria Rosaria, IT
TONTINI, Marta, IT
BERTI, Francesco, IT
MICOLI, Francesca, IT
KABANOVA, Anna, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS |
| POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS |